Bandingkan Harga & Kinerja Daya Intiguna Yasa Tbk. (MDIY) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Daya Intiguna Yasa Tbk. dan Organon Pharma Indonesia Tbk.: Daya Intiguna Yasa Tbk. diperdagangkan di Rp935 (kapitalisasi pasar 23,43 T, volume 24 jam 434,3 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Daya Intiguna Yasa Tbk. jauh lebih besar — sekitar 224,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MDIY | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 23,43 T | 104,4 M |
Volume | 434,3 rb | — |
Lot | 4,34 rb | — |
Perputaran | 406,46 jt | — |
Harga Rata-rata | 935,89 | — |
Nilai Transaksi | 406,46 jt | — |
Harga Ekuilibrium Indikatif | 935 | — |
Volume Ekuilibrium Indikatif | 83 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Daya Intiguna Yasa Tbk.
PT Daya Intiguna Yasa Tbk (the Company) was established based on Notarial Deed No. 7 dated 27 March 2017 of notary Drs. Bambang T Anggono Budi, S.H., M.Kn. The Company commenced its commercial operations on March 2017. The Company direct parent entity is Azara Alpina Sdn Bhd, a company incorporated and domiciled in Malaysia. The Company ultimate parent and individual entity is Mr DIY International Holding Ltd and Mr. Tan Yu Yeh, a company and individual that incorporated and domiciled in Malaysia.
Selengkapnya di halaman MDIY →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
